Literature DB >> 11014007

[Fulminant liver failure: etiopathogenesis and therapy].

L Fogli1, P Gorini, E Morsiani.   

Abstract

Fulminant hepatic failure (FHF) is a clinical syndrome characterized by the development of encephalopathy within eight weeks from the onset of the first symptoms, in the absence of previous hepatic disease. It is an uncommon but not rare disease, often fatal but potentially reversible. This article looks at the diverse aetiologies, clinical features, and current medical management, including orthotopic liver transplantation, and auxiliary orthotopic or eterotopic liver transplantation, that are the most recently adopted surgical procedures. Clinical experience with bio-artificial liver support systems of two of the most active research Groups in this field, concludes the paper.

Entities:  

Mesh:

Year:  2000        PMID: 11014007

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  1 in total

1.  TECA hybrid artificial liver support system in treatment of acute liver failure.

Authors:  Y L Xue; S F Zhao; Y Luo; X J Li; Z P Duan; X P Chen; W G Li; X Q Huang; Y L Li; X Cui; D G Zhong; Z Y Zhang; Z Q Huang
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.